In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Iron III Hydroxide Polymaltose Complex Drug Master File in Korea (Iron III Hydroxide Polymaltose Complex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Iron III Hydroxide Polymaltose Complex. The MFDS reviews the Iron III Hydroxide Polymaltose Complex KDMF as part of the drug registration process and uses the information provided in the Iron III Hydroxide Polymaltose Complex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Iron III Hydroxide Polymaltose Complex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Iron III Hydroxide Polymaltose Complex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Iron III Hydroxide Polymaltose Complex suppliers with KDMF on PharmaCompass.